Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Effects of Methylphenidate in ADHD
NCT04781972Phase 4Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jul 2021
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Johns Hopkins University. Started Jul 2021; status: recruiting.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04781972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04781972.